Evidence map›Paper›PMID 30518728›Full record

Observational studyJournal of atherosclerosis and thrombosis2019

Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study.

Masato Nakamura, Junya Ako, Hidenori Arai, Atsushi Hirayama, Yoshitaka Murakami, Atsushi Nohara, Kiyoko Uno, Asuka Ozaki, Mariko Harada-Shiba

Open access · diamondAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of atherosclerosis and thrombosis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Observational
  4. Observational
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Masato NakamuraDivision of Cardiovascular Medicine, Toho University Ohashi Medical Center.
Junya AkoDepartment of Cardiovascular Medicine, Kitasato University.
Hidenori AraiDepartment of Geriatric Medicine, National Center for Geriatrics and Gerontology.
Atsushi HirayamaCardiovascular Division, Osaka Police Hospital.
Yoshitaka MurakamiDepartment of Medical Statistics, Toho University.
Atsushi NoharaDepartment of Lipidology, Kanazawa University of Graduate School of Medical Sciences.
Kiyoko UnoCardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi.
Asuka OzakiCardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi.
Mariko Harada-ShibaDepartment of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute.
Sanofi (France) · FRToho University · JPKanazawa University · JPKitasato University · JPNational Center for Geriatrics and Gerontology · JPNational Cerebral and Cardiovascular Center · JPOsaka Police Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe EXPLORE-J study aimed to assess lipid management in patients hospitalized for acute coronary syndrome (ACS) and their cardiovascular risk despite undergoing standard therapy. Here, we focused on background characteristics of patients in the EXPLORE-J study to elucidate the current lipid-lowering therapy and its issues in Japan.

methodsIn this multicenter, prospective, observational study (UMIN000018946), consecutive Japanese ACS patients who required hospitalization were registered between April 2015 and August 2016. Background and lipid profile data collected within 14 days of hospitalization were analyzed according to risk factors such as diabetes mellitus status.

resultsIn total, 1944 patients were analyzed (80.3% male). The mean and standard deviation (SD) age and body mass index of all patients were 66.0 years (SD: 12.2) and 24.24 kg/m

conclusionsMany patients were not meeting Japanese LDL-C target levels at the time of ACS, and a large proportion of patients meeting target levels developed ACS; therefore, more stringent management and further evaluation of the target LDL-C levels is warranted in high-risk patients and those with previous history of CAD.

Indexed as

Acute Coronary SyndromeAgedAnticholesteremic AgentsBiomarkersCholesterol, LDLFemaleFollow-Up StudiesHumansHyperlipidemiasJapanLipidsMalePrognosisProspective StudiesAnticholesteremic AgentsBiomarkersCholesterol, LDLLipidsAcute coronary syndromeCardiovascular riskJapanLow-density lipoprotein cholesterol

Identifiers

PMID30518728
PMCPMC6545456
OpenAlexW2903059170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.